Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rodriguez, M.
Right arrow Articles by Kurland, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rodriguez, M.
Right arrow Articles by Kurland, L.
NEUROLOGY 1994;44:28
© 1994 American Academy of Neurology

Impairment, disability, and handicap in multiple sclerosis

A population-based study in Olmsted County, Minnesota

M. Rodriguez, MD, A. Siva, MD, J. Ward, K. Stolp-Smith, MD, P. O'Brien, PhD and L. Kurland, MD, DrPH

Departments of Neurology (Drs. Rodriguez and Siva), Health Sciences Research (Clinical Epidemiology and Biostatistics) (Drs. Siva, O'Brien, and Kurland, and J. Ward), and Physical Medicine and Rehabilitation (K. Stolp-Smith), Mayo Clinic/Foundation, Rochester, MN.

We studied functional status of MS patients in a geographically based cohort in Olmsted County, Minnesota. The 162 definite MS patients who were alive and residing in the study area on December 1, 1991, constituted the MS prevalence disability cohort. We identified 179 cases of definite or probable MS, providing an overall sex-and age-adjusted prevalence rate of 167.5 per 100,000. Median duration of MS from onset was 15.4 years, and median age on prevalence date was 47.5 years. The Minimal Record of Disability for MS determined the degree of impairment, disability, and handicap of the entire cohort within 4 months of the prevalence date. The frequency of Expanded Disability Status Scale scores of the MS prevalence cohort showed a bimodal distribution with peaks at 1 and 6.5 (3.5 [1 to 9.5], median [range]). Approximately one-third of the cohort had marked paraparesis, paraplegia, or quadriplegia. One-fourth of all patients needed intermittent or almost constant catheterization for bladder dysfunction. Few patients (3.7%) reported severe decrease in mentation or dementia requiring supervision. Many patients (53.1%) were working full-time. Most patients (72.2%) maintained their usual financial standard without external support. There were no differences in level of impairment, disability, or handicap observed between the subgroup of 122 patients (75.3%) who are incident cases (onset of disease as residents of Olmsted County) compared with the entire prevalence cohort. This geographically based study of MS demonstrates that the functional status is more favorable than previously recognized.

Address correspondence and reprint requests to Dr. Moses Rodriguez, Mayo Clinic/Foundation, Department of Neurology, Rochester, MN 55905.

Dr. Siva conducted this research while he was a visiting scientist; he is currently an Associate Professor, Neurology Department, Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey.

Received April 1, 1993. Accepted for publication in final form June 14, 1993.




This article has been cited by other articles:


Home page
Mult SclerHome page
K Gottberg, U Einarsson, C Ytterberg, S Fredrikson, L von Koch, and L W. Holmqvist
Use of health care services and satisfaction with care in people with multiple sclerosis in Stockholm County: A population-based study
Multiple Sclerosis, August 1, 2008; 14(7): 962 - 971.
[Abstract] [PDF]


Home page
NeurologyHome page
D. Hirtz, D. J. Thurman, K. Gwinn-Hardy, M. Mohamed, A. R. Chaudhuri, and R. Zalutsky
How common are the "common" neurologic disorders?
Neurology, January 30, 2007; 68(5): 326 - 337.
[Abstract] [Full Text] [PDF]


Home page
Clin RehabilHome page
U Einarsson, K Gottberg, S Fredrikson, L von Koch, and L W. Holmqvist
Activities of daily living and social activities in people with multiple sclerosis in Stockholm County
Clinical Rehabilitation, June 1, 2006; 20(6): 543 - 551.
[Abstract] [PDF]


Home page
Mult SclerHome page
U Einarsson, K Gottberg, L von Koch, S Fredrikson, C Ytterberg, Y P Jin, M Andersson, and L W. Holmqvist
Cognitive and motor function in people with multiple sclerosis in Stockholm County
Multiple Sclerosis, June 1, 2006; 12(3): 340 - 353.
[Abstract] [PDF]


Home page
Am. J. Neuroradiol.Home page
M. Inglese
Multiple sclerosis: new insights and trends.
AJNR Am. J. Neuroradiol., May 1, 2006; 27(5): 954 - 957.
[Full Text] [PDF]


Home page
NeurologyHome page
S. J. Pittock, W. T. Mayr, R. L. McClelland, N. W. Jorgensen, S. D. Weigand, J. H. Noseworthy, and M. Rodriguez
Disability profile of MS did not change over 10 years in a population-based prevalence cohort
Neurology, February 24, 2004; 62(4): 601 - 606.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
S. J. Pittock, W. T. Mayr, R. L. McClelland, N. W. Jorgensen, S. D. Weigand, J. H. Noseworthy, B. G. Weinshenker, and M. Rodriguez
Change in MS-related disability in a population-based cohort: A 10-year follow-up study
Neurology, January 13, 2004; 62(1): 51 - 59.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
S. Tuzun, A. AltWntas, I. Karacan, S. Tangurek, S. Saip, and A. Siva
Bone status in multiple sclerosis: beyond corticosteroids
Multiple Sclerosis, December 1, 2003; 9(6): 600 - 604.
[Abstract] [PDF]


Home page
NeurologyHome page
R.B. Lipton, S.D. Silberstein, J.R. Saper, M.E. Bigal, and P.J. Goadsby
Why headache treatment fails
Neurology, April 8, 2003; 60(7): 1064 - 1070.
[Abstract] [Full Text] [PDF]


Home page
Clin RehabilHome page
U Einarsson, K Gottberg, S Fredrikson, G Bergendal, L von Koch, and L W. Holmqvist
Multiple sclerosis in Stockholm County. A pilot study exploring the feasibility of assessment of impairment, disability and handicap by home visits
Clinical Rehabilitation, March 1, 2003; 17(3): 294 - 303.
[Abstract] [PDF]


Home page
NeurologyHome page
S. Kikuchi, T. Fukazawa, M. Niino, I. Yabe, R. Miyagishi, T. Hamada, S. A. Hashimoto, and K. Tashiro
HLA-related subpopulations of MS in Japanese with and without oligoclonal IgG bands
Neurology, February 25, 2003; 60(4): 647 - 651.
[Abstract] [Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
P. A. Nyquist, G. D. Cascino, R. L. McClelland, J. F. Annegers, and M. Rodriguez
Incidence of Seizures in Patients With Multiple Sclerosis: A Population-Based Study
Mayo Clin. Proc., September 1, 2002; 77(9): 910 - 912.
[Abstract] [PDF]


Home page
NeurologyHome page
C. W. Noonan, S. J. Kathman, and M. C. White
Prevalence estimates for MS in the United States and evidence of an increasing trend for women
Neurology, January 8, 2002; 58(1): 136 - 138.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
F. Fazekas, S. Strasser-Fuchs, H. Kollegger, T. Berger, W. Kristoferitsch, H. Schmidt, C. Enzinger, M. Schiefermeier, C. Schwarz, B. Kornek, et al.
Apolipoprotein E {epsilon}4 is associated with rapid progression of multiple sclerosis
Neurology, September 11, 2001; 57(5): 853 - 857.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
J. A. Cohen, G. R. Cutter, J. S. Fischer, A. D. Goodman, F. R. Heidenreich, A. J. Jak, J. E. Kniker, M. F. Kooijmans, J. M. Lull, A. W. Sandrock, et al.
Use of the Multiple Sclerosis Functional Composite as an Outcome Measure in a Phase 3 Clinical Trial
Arch Neurol, June 1, 2001; 58(6): 961 - 967.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
G V McDonnell and S A Hawkins
An assessment of the spectrum of disability and handicap in multiple sclerosis: a population-based study
Multiple Sclerosis, April 1, 2001; 7(2): 111 - 117.
[Abstract] [PDF]


Home page
NEJMHome page
J. H. Noseworthy, C. Lucchinetti, M. Rodriguez, and B. G. Weinshenker
Multiple Sclerosis
N. Engl. J. Med., September 28, 2000; 343(13): 938 - 952.
[Full Text] [PDF]


Home page
NeurologyHome page
J. A. Cohen, J. S. Fischer, D. M. Bolibrush, A. J. Jak, J. E. Kniker, L. A. Mertz, T. T. Skaramagas, and G. R. Cutter
Intrarater and interrater reliability of the MS functional composite outcome measure
Neurology, February 22, 2000; 54(4): 802 - 806.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
B. Sharrack and R. A. Hughes
The Guy's Neurological Disability Scale (GNDS): a new disability measure for multiple sclerosis
Multiple Sclerosis, August 1, 1999; 5(4): 223 - 233.
[Abstract] [PDF]


Home page
NeurologyHome page
B. G. Weinshenker, D. Hebrink, D. M. Wingerchuk, C. J. Klein, E. Atkinson, P. C. O'Brien, and C. T. McMurray
Genetic variants in the tumor necrosis factor receptor 1 gene in patients with MS
Neurology, April 1, 1999; 52(7): 1500 - 1500.
[Abstract] [Full Text]


Home page
BrainHome page
B. Sharrack, R. A. C. Hughes, S. Soudain, and G. Dunn
The psychometric properties of clinical rating scales used in multiple sclerosis
Brain, January 1, 1999; 122(1): 141 - 159.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
D. S Goodin
A questionnaire to assess neurological impairment in multiple sclerosis
Multiple Sclerosis, October 1, 1998; 4(5): 444 - 451.
[Abstract] [PDF]


Home page
Neurorehabil Neural RepairHome page
D. C. Quick and R. T. Schapiro
Population Dynamics of the Disability Status Scales for Multiple Sclerosis
Neurorehabil Neural Repair, January 1, 1996; 10(2): 127 - 134.
[Abstract] [PDF]


Home page
Neurorehabil Neural RepairHome page
M. Namey, L. Morgante, I. M. Clesson, N. Holland, B. Perry, C. Saunders, and B. Layton
Developing Proposals for Nursing Research
Neurorehabil Neural Repair, January 1, 1994; 8(3): 113 - 118.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by AAN Enterprises, Inc.